Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma: Is It Really Better To Fix What Is Broken?

Research output: Contribution to journalComment/debateResearchpeer-review

Standard

Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma : Is It Really Better To Fix What Is Broken? / Teraa, Martin; Resch, Timothy A.

In: European Journal of Vascular and Endovascular Surgery, Vol. 67, No. 4, 2024, p. 593.

Research output: Contribution to journalComment/debateResearchpeer-review

Harvard

Teraa, M & Resch, TA 2024, 'Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma: Is It Really Better To Fix What Is Broken?', European Journal of Vascular and Endovascular Surgery, vol. 67, no. 4, pp. 593. https://doi.org/10.1016/j.ejvs.2023.12.030

APA

Teraa, M., & Resch, T. A. (2024). Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma: Is It Really Better To Fix What Is Broken? European Journal of Vascular and Endovascular Surgery, 67(4), 593. https://doi.org/10.1016/j.ejvs.2023.12.030

Vancouver

Teraa M, Resch TA. Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma: Is It Really Better To Fix What Is Broken? European Journal of Vascular and Endovascular Surgery. 2024;67(4):593. https://doi.org/10.1016/j.ejvs.2023.12.030

Author

Teraa, Martin ; Resch, Timothy A. / Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma : Is It Really Better To Fix What Is Broken?. In: European Journal of Vascular and Endovascular Surgery. 2024 ; Vol. 67, No. 4. pp. 593.

Bibtex

@article{06687eb8f6d74c98a10247b50c6aac76,
title = "Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma: Is It Really Better To Fix What Is Broken?",
abstract = "In the current meta-analysis including a total of eight observational studies Pompeu S{\'a} and colleagues report the pooled data of patients who underwent thoracic endovascular aortic repair (TEVAR; n = 440) or best medical therapy (BMT; n = 575) for acute type B intramural haematoma (IMH).1 After a median follow up of 5.1 years TEVAR was associated with a reduced all cause (HR 0.44, 95% CI 0.30 – 0.65, p < .001) and aortic related (HR 0.04, 95% CI 0.01 – 0.31, p = .002) mortality. The authors therefore cautiously conclude that TEVAR might lead to a lower risk of all cause and aortic specific mortality in patients with type B IMH compared with BMT alone.",
author = "Martin Teraa and Resch, {Timothy A.}",
year = "2024",
doi = "10.1016/j.ejvs.2023.12.030",
language = "English",
volume = "67",
pages = "593",
journal = "European Journal of Vascular and Endovascular Surgery",
issn = "1078-5884",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Thoracic Endovascular Repair in Acute Type B Aortic Intramural Haematoma

T2 - Is It Really Better To Fix What Is Broken?

AU - Teraa, Martin

AU - Resch, Timothy A.

PY - 2024

Y1 - 2024

N2 - In the current meta-analysis including a total of eight observational studies Pompeu Sá and colleagues report the pooled data of patients who underwent thoracic endovascular aortic repair (TEVAR; n = 440) or best medical therapy (BMT; n = 575) for acute type B intramural haematoma (IMH).1 After a median follow up of 5.1 years TEVAR was associated with a reduced all cause (HR 0.44, 95% CI 0.30 – 0.65, p < .001) and aortic related (HR 0.04, 95% CI 0.01 – 0.31, p = .002) mortality. The authors therefore cautiously conclude that TEVAR might lead to a lower risk of all cause and aortic specific mortality in patients with type B IMH compared with BMT alone.

AB - In the current meta-analysis including a total of eight observational studies Pompeu Sá and colleagues report the pooled data of patients who underwent thoracic endovascular aortic repair (TEVAR; n = 440) or best medical therapy (BMT; n = 575) for acute type B intramural haematoma (IMH).1 After a median follow up of 5.1 years TEVAR was associated with a reduced all cause (HR 0.44, 95% CI 0.30 – 0.65, p < .001) and aortic related (HR 0.04, 95% CI 0.01 – 0.31, p = .002) mortality. The authors therefore cautiously conclude that TEVAR might lead to a lower risk of all cause and aortic specific mortality in patients with type B IMH compared with BMT alone.

U2 - 10.1016/j.ejvs.2023.12.030

DO - 10.1016/j.ejvs.2023.12.030

M3 - Comment/debate

C2 - 38176450

AN - SCOPUS:85185164761

VL - 67

SP - 593

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

SN - 1078-5884

IS - 4

ER -

ID: 386455327